Showing 1 - 10 of 9,423
Persistent link: https://www.econbiz.de/10003892769
Persistent link: https://www.econbiz.de/10014565328
Persistent link: https://www.econbiz.de/10001790851
Starting from December 2012, insurers in the European Union were prohibited from charging gender-discriminatory prices. We examine the effect of this unisex mandate on risk segmentation in the German health insurance market. While gender used to be a pricing factor in Germany's private health...
Persistent link: https://www.econbiz.de/10011961924
Starting from December 2012, insurers in the European Union were prohibited from charging gender-discriminatory prices. We examine the effect of this unisex mandate on risk segmentation in the German health insurance market. While gender used to be a pricing factor in Germany's private health...
Persistent link: https://www.econbiz.de/10011968915
Starting from December 2012, insurers in the European Union were prohibited from charging gender-discriminatory prices. We examine the effect of this unisex mandate on risk segmentation in the German health insurance market. While gender used to be a pricing factor in Germany's private health...
Persistent link: https://www.econbiz.de/10011951076
Persistent link: https://www.econbiz.de/10011783162
We present robust evidence on the presence of adverse selection in hospitalization insurance for low-income households. A large randomized control trial from Pakistan allows us to separate adverse selection from moral hazard, to estimate how selection changes at different points of the demand...
Persistent link: https://www.econbiz.de/10011896970
Universal health coverage is a widely shared goal across lower-income countries. We conducted a large-scale, 4-year trial that randomized premiums and subsidies for India's first national, public hospital insurance program, RSBY. We find roughly 60% uptake even when consumers were charged...
Persistent link: https://www.econbiz.de/10014504886
Universal health coverage is a widely shared goal across lower-income countries. We conducted a large-scale, 4-year trial that randomized premiums and subsidies for India's first national, public hospital insurance program, RSBY. We find roughly 60% uptake even when consumers were charged...
Persistent link: https://www.econbiz.de/10014495898